Esperion Therapeutics Inc (ESPR)
Cash & Short-Term Investments
$156.16M
Quarterly · Period ending: · USD
ESPR Cash & Short-Term Investments
Latest reported$156.16Mperiod ending
Latest reported$156.16Mperiod ending
ESPR Quarterly Cash & Short-Term Investments ($27.70M → $156.16M)
Quarterly Cash & Short-Term Investments
High-resolution chart · PNG
ESPR cash & short-term investments history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Short-Term Investments (USD) |
|---|---|
| 156,158,000 | |
| 167,852,000 | |
| 92,447,000 | |
| 86,061,000 | |
| 114,633,000 | |
| 144,761,000 | |
| 144,717,000 | |
| 189,304,000 | |
| 226,609,000 | |
| 82,248,000 | |
| 114,833,000 | |
| 138,470,000 | |
| 162,338,000 | |
| 166,861,000 | |
| 189,341,000 | |
| 185,845,000 | |
| 218,502,000 | |
| 259,333,000 | |
| 103,672,000 | |
| 219,186,000 | |
| 217,939,000 | |
| 304,962,000 | |
| 215,748,000 | |
| 300,736,000 | |
| 157,317,000 | |
| 200,781,000 | |
| 243,861,000 | |
| 301,226,000 | |
| 228,528,000 | |
| 36,973,000 | |
| 159,218,000 | |
| 180,173,000 | |
| 197,223,000 | |
| 34,468,000 | |
| 203,371,000 | |
| 167,408,000 | |
| 181,884,000 | |
| 38,165,000 | |
| 210,101,000 | |
| 207,178,000 | |
| 194,470,000 | |
| 77,336,000 | |
| 215,596,000 | |
| 224,782,000 | |
| 278,108,000 | |
| 85,038,000 | |
| 52,961,000 | |
| 59,724,000 | |
| 56,702,000 | |
| 60,062,484 | |
| 71,895,828 | |
| 16,626,859 | |
| 20,886,216 | |
| 6,511,521 | |
| 92,392,000 | |
| 32,225,000 | |
| 37,858,000 | |
| 44,853,000 | |
| 49,746,000 | |
| 56,762,000 | |
| 63,923,000 | |
| 70,286,000 | |
| 76,985,000 | |
| 60,721,000 | |
| 64,661,000 | |
| 70,228,000 | |
| 75,638,000 | |
| 22,685,000 | |
| 27,698,068 |